1-11 of 11
Tomas García
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunotherapy May be Preferable to Chemotherapy As Second-Line Treatment for POD24 Follicular Lymphoma (FL) Patients

Ángel Serna, Marc Bosch, Victor Navarro Garces, Patricia Lopez Pereira, David Quintela, Juan-Manuel Sancho, Adolfo Jesús Sáez Marín, Ana Jiménez Ubieto, Alberto López, Raul Cordoba, Maria Cerdá, Beatriz De La Cruz, Samuel Romero, Ainara Ferrero, Tomas Garcia Cerecedo, Teresa Villalobos, Andrea Rivero, Cristina García, Ana Marín Niebla, Gloria Iacoboni, Francesc Bosch, Pau Abrisqueta Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 1658.
https://doi.org/10.1182/blood-2024-207871
Published: 2024
Journal Articles

Beyond MIPI: Harnessing Machine Learning and Histological Subtype for Enhanced MCL Prognostication of Survival

Adrian Mosquera Orgueira, Alba Carbita, Victor Navarro Garces, Pau Abrisqueta, Rodrigo Alonso Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 4419.
https://doi.org/10.1182/blood-2023-179174
Published: 2023
Journal Articles

Novel Agents May be Preferable to Standard Chemotherapy in Second-Line for Early Relapsing Follicular Lymphoma (FL) Patients

Angel Serna, Marc Bosch, Víctor Navarro, Patricia Lopez-Pereira, David Quintela, Mireia Franch, Juan-Manuel Sancho, Adolfo Jesús Sáez Marín, Maria Poza, Ana Jimenez Ubieto, Alberto Lopez Garcia, Raul Cordoba, Maria Cerdá, Beatriz De La Cruz, Samuel Romero, Ainara Ferrero, Tomas Garcia Cerecedo, Cristina García Herce, Alba Cabirta Touzón, Ana Marin Niebla, Gloria Iacoboni, Francesc Bosch, Pau Abrisqueta Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 6168.
https://doi.org/10.1182/blood-2023-186019
Published: 2023
Journal Articles

Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients

Josu Iraola-Truchuelo, Gloria Iacoboni, Laura Palomo, Victor Navarro Garces, Josep Castellvi, Alba Mas, Lara Nonell, Luis A Mayor, Victoria Dourdil, Tomas Garcia Cerecedo, Oriana López Godino, Mario Sánchez-Salinas, Cecilia Carpio, Marta Crespo, Angel Serna, Alba Cabirta Touzón, Marc Bosch, Cristina García, Pere Barba, Francesc Bosch, Pau Abrisqueta Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 1635.
https://doi.org/10.1182/blood-2023-186072
Published: 2023
Journal Articles

A Novel Machine-Learning Model to Predict Early Relapse in Mantle Cell Lymphoma (MCL)

Alba Cabirta Touzón, Adrian Mosquera Orgueira, Victor Navarro Garces, Pau Abrisqueta, Rodrigo A Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz Vicente, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 1675.
https://doi.org/10.1182/blood-2023-181628
Published: 2023
Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Christelle Ferra, María José Terol, Juan Marquet Palomanes, Angel Ramírez Payer, Carol Moreno, Santiago Osorio, Fátima De la Cruz, Jose A. Garcia-Marco, Macarena Ortiz, Eduardo Rios Herranz, Laura Magnano, Sandra Iraheta, Jose Manuel Puerta, Javier de la Serna, Alicia Smucler, Jose Maria Arguiñano, Javier Loscertales, Begoña Muiña, Rubén Fernández, Tomas García, José A. Márquez, Ana Muntañola Prat, Ernesto Perez Persona, Lucrecia Yáñez, Manuel Pérez-Encinas, Marcos González Díaz, Gonzalo Caballero, María Angeles Andreu, Rafael Andreu, Ana Ruiz-Zorrilla, Diana Moreno, Patricia Baltasar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9908–9910.
https://doi.org/10.1182/blood-2022-162186
Published: 2022
Journal Articles

Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)

Angel Serna, Angela Sanchez, Laia Lopez, Juan-Manuel Sancho, Eva Gonzalez Barca, Alberto Lopez-Garcia, Raul Cordoba, Adolfo Jesús Sáez Marín, Ana Isabel Jiminez Ubieto, Ainara Ferrero, Tomas García, Alba Cabirta, M Moraima Jimenez, Lucia Martin, Marta Julia, Sabela Bobillo, Ana Marin-Niebla, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2022) 140 (Supplement 1): 9350–9352.
https://doi.org/10.1182/blood-2022-165996
Published: 2022
Journal Articles

Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group

Teresa Villalobos, Ana Muntañola Prat, Sonia González de Villambrosia, Maria J. Rodriguez-Salazar, Ana Isabel Jiminez Ubieto, Gabriela Bastidas-Mora, Raul Cordoba, Maria Stefania Infante, Maria Jesus Vidal, Francisco Javier Diaz-Galvez, Monica Baile, Mariana Bastos-Oreiro, Carlos Panizo, Juan-Manuel Sancho, Belen Navarro Matilla, Tomas García, Lourdes Escoda, Pau Abrisqueta, María José Terol, Raquel Del Campo, Armando López-Guillermo, Antonio Salar, Carlos Montalban
Journal: Blood
Blood (2022) 140 (Supplement 1): 9347–9349.
https://doi.org/10.1182/blood-2022-160073
Published: 2022
Journal Articles

Rituximab Maintenance (RM) after First-Line (1L) Treatment Is Associated with a Lower Risk of Early-POD in Patients with Mantle Cell Lymphoma (MCL)

Alba Cabirta, Pau Abrisqueta, Víctor Navarro Garcés, Marta Canelo-Vilaseca, Marina Gomez-Rosa, Alberto Lopez García, Tomas García, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Moraima Jiménez, Sabela Bobillo, Marta Julia, Cecilia Carpio, Gloria Iacoboni, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin-Niebla
Journal: Blood
Blood (2022) 140 (Supplement 1): 9335–9337.
https://doi.org/10.1182/blood-2022-163180
Published: 2022
Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Patricia Baltasar, María José Terol, Juan Marquet Palomanes, Angel Ramírez Payer, Carol Moreno, Santiago Osorio, Fátima De la Cruz, Jose A. Garcia-Marco, Sr., Macarena Ortiz, Eduardo Ríos Herranz, Laura Magnano, Sandra Iraheta, Jose Manuel Puerta, Javier de la Serna, Alicia Smucler Simonovich, Jose Maria Arguiñano, Javier Loscertales, Begoña Muiña, Ruben Fernandez, Tomas García, José A. Márquez, Ana Muntañola Prat, Ernesto Pérez Persona, Lucrecia Yáñez, Manuel Pérez-Encinas, Marcos González Díaz, Gonzalo Caballero, María Angeles Andreu, Rafael Andreu, Ana Ruiz-Zorrilla, Diana Moreno, Christelle Ferrà
Journal: Blood
Blood (2021) 138 (Supplement 1): 1561.
https://doi.org/10.1182/blood-2021-147685
Published: 2021
Journal Articles

Prognostic Factors and Treatment Results in Elderly Patients with Aggressive B-Cell Lymphoma: A Geltamo Observational Study

Emilia Pardal, MD PhD, Eva Diez-Baeza, PhD, Eva González-Barca, MD PhD, Tomas Garcia-Cerecedo, MD PhD, Encarna Monzo, MD PhD, Juan-Manuel Sancho, Jose Maria Moraleda, MDPhD, Raul Cordoba, MD PhD, Fatima De la Cruz, MD PhD, JA Queizan, MD PhD, Maria Rodriguez-Salazar, MD PhD, JA Hernández-Rivas, MD PhD, Belen Navarro, MD PhD, Rosana Diez-Angulo, MD PhD, Maria Cruz Viguria, MD PhD, Maria Vahi, MD PhD, Maria Jesús Peñarrubia, MD PhD, Monica Sanchez, PhD, Miguel Canales, MD PhD, Tomas Gonzalez, MD, Sara Alonso, MD, Maria Dolores Caballero, MD PhD, Alejandro Martin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1508.
https://doi.org/10.1182/blood.V126.23.1508.1508
Published: 2015